AMGEN ANNOUNCES WEBCAST OF 2025 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS

Amgen (NASDAQ:AMGN) will report fourth quarter and full year 2025 financial results on Tuesday, February 3, 2026, after U.S. market close.

Rhea-AI Summary

Amgen (NASDAQ:AMGN) will report fourth quarter and full year 2025 financial results on Tuesday, February 3, 2026, after U.S. market close. A conference call with management will follow at 4:30 p.m. ET, and live audio webcast will be available on Amgen's Investor Relations site.

The webcast will be archived and available for replay for at least 90 days on the company's website.

Argus Jan 29 session

+0.21% close to close Open Argus

Details

News Market Reaction – AMGN

In the Jan 29 session, AMGN gained 0.21%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement schedules AMGN’s Q4 and full-year 2025 earnings release for February 3, 2026, with...

Analysis

This announcement schedules AMGN’s Q4 and full-year 2025 earnings release for February 3, 2026, with a conference call at 4:30 p.m. ET and replay available for at least 90 days. It continues the company’s regular communication cadence seen across 2025 earnings events. Investors may track how upcoming results compare with prior quarters’ revenue and EPS growth and monitor any updates on product performance or guidance once detailed numbers are reported.

Key Figures

Earnings release date: February 3, 2026 Conference call time: 4:30 p.m. ET Webcast replay window: 90 days

Earnings release date

February 3, 2026

Scheduled Q4 and full-year 2025 financial results release

Conference call time

4:30 p.m. ET

Investor conference call following results release

Webcast replay window

90 days

Minimum period webcast will be available for replay

Previous Earnings Reports

5 past events · Latest: Nov 04

Same Type 5 events

1. Nov 04

   Q3 2025 results

   24h Move

   +0.1%

   Strong Q3 2025 revenue and EPS growth with guidance reiterated.

2. Oct 29

   Q3 2025 webcast

   24h Move

   +0.1%

   Scheduled Q3 2025 earnings webcast and conference call details.

3. Aug 05

   Q2 2025 results

   24h Move

   -5.1%

   Strong Q2 2025 results with broad product growth but some product headwinds.

4. Jul 31

   Q2 2025 webcast

   24h Move

   +0.6%

   Announcement of Q2 2025 earnings release timing and webcast access.

5. May 01

   Q1 2025 results

   24h Move

   -0.9%

   Strong Q1 2025 revenue and EPS with noted Otezla impairment charge.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

THOUSAND OAKS, Calif., Jan. 28, 2026 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its fourth quarter and full year 2025 financial results on Tuesday, February 3, 2026, after the close of the U.S. financial markets. The announcement will be followed by a conference call with the investment community at 4:30 p.m. ET. Participating in the call from Amgen will be Robert A. Bradway, chairman and chief executive officer, and other members of Amgen's senior management team.

Live audio of the conference call will be simultaneously broadcast over the internet and will be available to members of the news media, investors and the general public.

The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.

About Amgen
Amgen discovers, develops, manufactures and delivers innovative medicines to fight some of the world's toughest diseases. Harnessing the best of biology and technology, Amgen reaches millions of patients with its medicines. 

More than 45 years ago, Amgen helped establish the biotechnology industry at its U.S. headquarters in Thousand Oaks, California, and it remains at the cutting edge of innovation, using technology and human genetic data to push beyond what is known today. Amgen is advancing a broad and deep pipeline and portfolio of medicines to treat cancer, heart disease, inflammatory conditions, rare diseases and obesity and obesity-related conditions.  

Amgen has been consistently recognized for innovation and workplace culture, including honors from Fast Company and Forbes. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average^®, and it is also part of the Nasdaq-100 Index^®, which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization.  

For more information, visit Amgen.com and follow Amgen on X, LinkedIn, Instagram, YouTube, Facebook, TikTok and Threads. 

CONTACT: Amgen, Thousand Oaks
Elissa Snook, 609-251-1407 (media)
Casey Capparelli, 805-447-1746 (investors)  

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/amgen-announces-webcast-of-2025-fourth-quarter-and-full-year-financial-results-302673138.html

SOURCE Amgen

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Amgen (AMGN) release its Q4 and full year 2025 results?

Amgen will release Q4 and full year 2025 results on Tuesday, February 3, 2026, after market close. According to Amgen, a conference call with management follows at 4:30 p.m. ET and a live webcast will be available on the Investor Relations site for public access.

How can investors access the Amgen (AMGN) webcast for the February 3, 2026 results?

Investors can access the live webcast on Amgen's Investor Relations website at www.amgen.com under Investors. According to Amgen, the audio broadcast will be simultaneous and viewers should check the Investor Relations Events Calendar for links and presentation times.

Who will participate on Amgen's (AMGN) February 3, 2026 earnings call?

Amgen's chairman and chief executive officer Robert A. Bradway and other senior management will participate on the call. According to Amgen, the management team will present results and take questions during the 4:30 p.m. ET conference call following the earnings release.

What time is the Amgen (AMGN) Q4 2025 conference call on February 3, 2026?

The conference call is scheduled for 4:30 p.m. ET on February 3, 2026, immediately after the results release. According to Amgen, live audio will be broadcast over the internet and the webcast link is listed on the company's Investor Relations Events Calendar.

How long will Amgen (AMGN) archive the Q4 and full year 2025 webcast replay?

Amgen will archive the webcast replay for at least 90 days after the event. According to Amgen, archived audio and presentation materials will remain available via the Investor Relations site for media, investors, and the general public to replay.